期刊文献+

CpG ODN佐剂促进HBsAg疫苗诱导小鼠细胞免疫应答的探讨 被引量:4

CpG ODN adjuvant enhances the cellular immune response in mice vaccinated with recombinant hepatitis B surface antigen
下载PDF
导出
摘要 目的 探讨cpG ODN对重组乙型肝炎表面抗原(HBsAg)诱导小鼠细胞免疫应答的影响。方法HBsAg和HBsAg+CpG ODN分别肌肉注射免疫Balb/c小鼠后,从淋巴组织(脾和淋巴结)和非淋巴组织(肺)分离淋巴细胞,体外经HBsAg抗原刺激后,利用ELISA检测细胞培养液中IFN-γ的水平,再利用流式细胞仪在单个细胞水平上检测IFN-γ^+细胞的频率,分析IFN-7^+细胞亚群。结果对照组和HBsAg免疫组IFN-γ产生的水平很低,当HBsAg加强免疫1~2次后,IFN-γ表达仍然没有明显升高;而CpG ODN+HBsAg免疫1次或加强免疫后,CpG显著促进HBsAg诱导的IFN-γ产生。进一研究结果表明CpG促进HBsAg诱导淋巴器官和非淋巴器官内CD4^+和CD8^+T细胞IFN-γ的表达。结论CpG免疫佐剂不仅能诱导细胞免疫应答同时也诱导体液免疫应答,提示CpG ODN可以用于HBsAg预防和治疗性佐剂。 Objective To investigate the effects of synthetic oligodeoxynucleotide containing CpG motifs (CpG ODN) on the cellular immune response in mice immunized with hepatitis B surface antigen (rHBsAg). Methods Balb/c mice were immunized i.m. with HBsAg or HBsAg + CpG ODN. Single cell suspensions were prepared from lymphoid ( spleens and lymph nodes) and non-lymphoid tissues (lung). The cells were then stimulated with HBsAg. IFN-γ in culture supernatants was assessed by ELISA. The IFN-γ-producing cell subsets were determined and analyzed by FACS. Results HBsAg immunization was not able to induce detectable levels of IFN-γ production. CpG could significantlyelevate the HBsAg-induced IFN-γ production by lymphoid and non-lymphoid tissues after prime and boost vaccination. Moreover, CpG promoted IFN-γ expression by both CD4^+ and CD8^+ T cells. Conclusion CpG ODN can enhance both cellular and humoral immune responses induced by HBsAg in lymphoid and non-lymphoid organs.
出处 《免疫学杂志》 CAS CSCD 北大核心 2006年第3期235-238,共4页 Immunological Journal
基金 国家重点基础研究发展计划项目(973 2001CB510007) 广州市科技局创新药物专项项目(2004Z3-E4031) 广东省自然科学基金重点项目(04105349)资助
关键词 CPG 0DN HBSAG 疫苗 佐剂 CpG ODN HBsAg Vaccine Adjuvant
  • 相关文献

参考文献12

  • 1Rhee EG, Mendez S, Shah JA, et al. Vaccination with heatkilled leishmania antigen or recombinant leishmanial protein and CpG oligodeoxynucleotides induces long-term memory CD4^+ and CD8^+ T cell responses and protection against leishmania major infection [ J]. J Exp Med, 2002,195 (12) : 1 565 - 1 573.
  • 2石艳春,杨贵贞.CpG ODN增强乙型肝炎表面抗原免疫小鼠的抗体产生[J].中国免疫学杂志,2003,19(1):9-11. 被引量:11
  • 3Shah JA, Darrah PA, Ambrozak DR, et al. Dendritic cells are responsible for the capacity of CpG oligodeoxynucleotides to act as an adjuvant for protective vaccine immunity against Leishmania major in mice [J]. J Exp Med, 2003, 198 (2) :281 - 291.
  • 4Chen L, Jondal M. Alternative processing for MHC class Ⅰ presentation by immature and CpG-activated dendritic cells [J]. Eur J Immunol, 2004, 34 (4): 952-960 .
  • 5Edwards L, Williams AE, Krieg AM, et al. Stimulation via Toll-like receptor 9 reduces Cayptococcus neoformans-induced pulmonary inflammation in an IL-12-dependent manner [J].Eur J Immunol, 2005, 35 ( 1 ) : 273 - 281.
  • 6Kandimalla ER, Bhagat L, Li Y, et al. Immunomodulatory oligonucleotides containing a cytosine-phosphate-2 '-deoxy-7-deazaguanosine motif as potent toll-like receptor 9 agonists [J]. Proc Natl Acad Sci USA, 2005, 102 (19) : 6 925-6 930.
  • 7Jiang JQ, Patrick A, Moss RB, et al. CD8^+ T-cell-mediated cross-clade protection in the genital tract following intranasal immunization with inactivated human immunodeficiency virus antigen plus CpG oligodeoxynucleotides [J]. J Virol, 2005,79 (1): 393-400.
  • 8Wang S, Liu X, Caulfield MJ. Adjuvant synergy in the response to hepatitis B vaccines [J]. Vaccine, 2003, 21 (27/30): 4297-4306.
  • 9杨滨燕,朱兆玲,吴长有.CD4^+T细胞的分裂与表面标志和细胞因子产生相关性的探讨[J].中国免疫学杂志,2004,20(9):587-590. 被引量:16
  • 10Rovers MM,Schilder AG,Zielhuis GA,Rosenfeld RM,张江平,杨妙丽,张全安.中耳炎[J].国外医学(耳鼻咽喉科学分册),2005,29(3):141-143. 被引量:427

二级参考文献37

  • 1吴长有.免疫记忆与疫苗研究开发[J].中国免疫学杂志,2005,21(1):4-7. 被引量:29
  • 2吴长有.初始和记忆T细胞的研究进展[J].现代免疫学,2005,25(5):353-356. 被引量:32
  • 3[1]Krieg A M. CpG motifs in bacterial DNA and their immune effects[J].Annual Rev Immunol,2002;20:709.
  • 4[2]Klinman DM, Conover J, Coban C. Repeated administration of synthetic oligodeoxynucleotides expressing CpG motifs provides long-term protection against bacterial infection[J] .Infection and Immunity, 1999;67(11):5658.
  • 5[3]Krieg AM, Davis HL. Enhancing vaccines with immune stimulatory CpG DNA[J].Current Opinion in Molecular Theraputics,2001;3(1) :15.
  • 6[4]Krieg AM, MatsonS, Waldschmidt T J et al. CpG motifs in bacterial DNA trigger direct B-cell activation[J].Natuwe, 1995;374(6522):546.
  • 7[6]Weeratna R D, McCluakie M J, Xu Y et al.CpG DNA induces stronger immune responses with less toxicity than other adjuvants[J] .Vaccine,2000; 18(1): 1755.
  • 8[7]Krieg A M, Wagner H. Causing a commotion in the blood:immunotherapy progress from bacterial to bacterial DNA[J] .Immunology Today,2000; 21 (10) :521.
  • 9[8]Liang H, Nishiok Y, Reich C F et al. Activation of human B cells by phospho riothioate oligodeoxynucleotides[J]. J Clin Invest, 1996;98(5):1119.
  • 10Abbas AK , Murphy KM , Sher A . Functional diversity of helper T lymphocytes [J]. Nature, 1996, 383 (6 603):787 - 793.

共引文献469

同被引文献60

引证文献4

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部